Net Loss of Norris Medicines reported to Rs 0.27 crore in the quarter ended December 2023 as against net loss of Rs 0.20 crore during the previous quarter ended December 2022. Sales declined 79.43% to Rs 0.65 crore in the quarter ended December 2023 as against Rs 3.16 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales0.653.16 -79 OPM %-6.1510.76 - PBDT-0.13-0.05 -160 PBT-0.27-0.20 -35 NP-0.27-0.20 -35 Powered by Capital Market - Live News

Norris Medicines will hold a meeting of the Board of Directors of the Company on 14 February 2024. The meeting would commence at 11.00 am.Powered by Capital Market - Live News

Norris Medicines announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 30 January 2024 .Powered by Capital Market - Live News

Norris Medicines will hold a meeting of the Board of Directors of the Company on 29 December 2023.Powered by Capital Market - Live News

Norris Medicines announced that the Annual General Meeting (AGM) of the company will be held on 14 December 2023.Powered by Capital Market - Live News